Regístrese
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Performance of the Bethesda System in the Cytopathological Diagnosis of the Thyr...
Journal Information
Vol. 96. Issue 9.
Pages 599-600 (November 2018)
Vol. 96. Issue 9.
Pages 599-600 (November 2018)
Letter to the Editor
DOI: 10.1016/j.cireng.2018.10.011
Full text access
Performance of the Bethesda System in the Cytopathological Diagnosis of the Thyroid Nodule
Rendimiento del sistema Bethesda en el diagnóstico citopatológico del nódulo tiroideo
Visits
219
Laura Granel-Villacha,
Corresponding author
laura_9487@yahoo.es

Corresponding author.
, Carlos Fortea-Sanchisb, José Manuel Laguna-Sastrea, Javier Escrig-Sosa
a Servicio Cirugía General y del Aparato Digestivo, Hospital General Universitario de Castellón, Castellón de la Plana, Castellón, Spain
b Servicio Cirugía General y del Aparato Digestivo, Consorcio Hospital Provincial de Castellón, Castellón de la Plana, Castellón, Spain
Related content
Cir Esp. 2018;96:363-810.1016/j.cireng.2018.06.007
Ismael Mora-Guzmán, José Luis Muñoz de Nova, Cristina Marín-Campos, José Antonio Jiménez-Heffernan, Juan Julián Cuesta Pérez, Marcos Lahera Vargas, Emma Torres Mínguez, Elena Martín-Pérez
This item has received
219
Visits
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear Editor,

We have read with great interest the article by Mora-Guzmán et al.1 about the performance of the Bethesda system in the cytopathologic diagnosis of thyroid nodules. For the purpose of this study, we would like to complete the information of the authors by reporting our experience.2 The standardization of the terminology used for the description of thyroid cytology is essential to be able to adapt the therapeutic approach with the utmost precision. In our experience, the results from thyroid fine needle aspiration (FNA) samples analyzed before implementing the Bethesda system were very low quality, so that in 27.7% of the cases there was no concordance between the results of the FNA and the definitive pathology study, with 54.5% of false negatives and 13.9% false positives in 112 patients analyzed. This represents a positive predictive value (PPV) of 57.7% and a negative predictive value (NPV) of 79.1%, which are very poor rates compared with the results obtained by Mora-Guzmán et al., who reported a NPV of 99.5% and a PPV of 93.5%.

One of the difficulties posed by the authors is the importance of the differentiation between category III and category V, although they describe results that are close to what is recommended.3,4 With regard to category I, the scarce number obtained is noteworthy and is attributed to the fact that all FNA were ultrasound-guided and without aspiration.5 Our results were only classified as positive or negative according to whether or not there were signs of malignancy. The FNA was negative in 76.8% and positive in 23% of the cases. In our case, ultrasound was rarely used, except in non-palpable nodules, one could think that this might also be related to the poor results obtained. We are currently awaiting a new evaluation of results after the standardization of the technique with the Bethesda system, but a priori, after a preliminary analysis and our clinical impression, it seems to indicate a clear improvement. In summary, we can conclude that the implementation of the Bethesda system is essential, since it is an easy and simple to use classification system that allows us to discern the risk of malignancy of a thyroid nodule with relative certainty. Nevertheless, as always, there are other factors, such as the specialist involved (in this case a cytologist), which would be difficult to measure and compare.

References
[1]
I. Mora-Guzmán, J.L. Muñóz de Nova, C. Marín-Campos, J.A. Jiménez-Jefferman, J.J. Cuesta-Pérez.
Rendimiento del sistema Bethesda en el diagnóstico citopatológico del nódulo tiroideo.
[2]
L. Granel-Villach, C. Fortea-Sanchis, J.M. Laguna-Sastre, J. Escrig-Sos, J.L. Salvador-Sanchís.
Rendimiento diagnóstico de la punción aspiración con aguja fina de tejido tiroideo.
Rev Colomb Cir, 31 (2016), pp. 103-110
[3]
M.E. Iskandar, G. Bonomo, V. Avadhani, M. Persky, D. Lucido, B. Wang, et al.
Evidence for overestimation of the prevalence of malignancy in indeterminate thyroid nodules classified as Bethesda category III.
Surgery, 157 (2015), pp. 510-517
[4]
J.F. Krane, P.A. Vanderlaan, W.C. Faquin, A.A. Renshaw.
The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio: a proposed performance measure for reporting in The Bethesda System for thyroid cytopathology.
Cancer Cytopathol, 120 (2012), pp. 111-116
[5]
M. Bongiovanni, A. Spitale, W.C. Faquin, L. Mazzucchelli, Z.W. Baloch.
The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis.
Acta Cytol, 56 (2012), pp. 333-339

Please cite this article as: Granel-Villach L, Fortea-Sanchis C, Laguna-Sastre JM, Escrig-Sos J. Rendimiento del sistema Bethesda en el diagnóstico cotopatológico del nódulo tiroideo. Cir Esp. 2018;96:599–600.

Copyright © 2018. AEC
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.